BCTXF - BriaCell Therapeutics Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue7/31/20187/31/20177/31/20167/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development3,042.7082,094.89837.587327.863
Selling General and Administrative1,457.584851.332691.46954.784
Non Recurring----
Others----
Total Operating Expenses4,976.5033,218.2362,177.1961,798.935
Operating Income or Loss-4,976.503-3,218.236-2,177.196-1,798.935
Income from Continuing Operations
Total Other Income/Expenses Net-436.16-2.485-37.586-1,689.876
Earnings Before Interest and Taxes-4,976.503-3,218.236-2,177.196-1,798.935
Interest Expense-20.364-20.364-20.364-20.364
Income Before Tax-5,412.663-3,220.721-2,214.782-3,488.811
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-5,412.663-3,220.721-2,214.782-3,488.811
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,412.663-3,220.721-2,214.782-3,488.811
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,412.663-3,220.721-2,214.782-3,488.811